Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you have taken more Mounjaro than prescribed, or you are worried about overdose symptoms from tirzepatide, the key facts are these: clinical trial data show no defined toxic overdose threshold has been established, but taking more than your prescribed dose can intensify gastrointestinal side effects and cause low blood sugar in certain circumstances. Call 111 or go to A&E if symptoms are severe. This page explains what to watch for, what to do, and when it becomes urgent, drawing on NHS guidance on tirzepatide. Mounjaro is a prescription-only medicine, and the right dose for you is decided by your prescriber after a full clinical assessment, not by the number on a pen.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro (tirzepatide) works by activating two gut-hormone receptors, GIP and GLP-1, that regulate appetite, insulin release and how quickly food leaves the stomach. When more of the medicine is present than the body is calibrated for, those same effects are simply amplified. The stomach empties more slowly than usual. Nausea climbs. The gut signals satiety more insistently than it should. This is why tirzepatide overdose symptoms in the clinical literature look a great deal like a severe version of the normal side-effect profile, rather than a distinct toxidrome.
There is no single dose that has been characterised as toxic in human studies, a fact that reflects how the medicine works rather than any suggestion it is without risk, and our page on whether you can overdose on Mounjaro explores this in detail. What has been observed in accidental or intentional excess dosing is a pronounced GI response: nausea that may be difficult to control, vomiting, abdominal cramping and diarrhoea. Dehydration follows quickly if vomiting and diarrhoea are both present, and that in turn can affect kidney function. If you are also taking medicines that lower blood sugar (including insulin or a sulfonylurea) hypoglycaemia becomes a realistic concern on top of the GI picture.
A question our prescribers hear most weeks, in one form or another, is whether accidentally giving yourself two injections in a row will cause serious harm. The honest answer is that it is unlikely to be dangerous in the way a paracetamol overdose would be, but it will almost certainly make you feel very unwell, and you should still contact your prescriber or call 111 rather than wait it out alone. You can read more about the full range of Mounjaro side effects and how they typically present.
The picture varies depending on your dose, whether you have type 2 diabetes and which other medicines you take. That said, the symptoms most commonly linked to excess tirzepatide exposure break into three groups.
First, gastrointestinal: persistent or severe nausea, repeated vomiting, watery diarrhoea, abdominal pain and bloating. These can begin within hours of an excess dose and may last a day or two. Staying hydrated is important, but if you cannot keep fluids down, that is a reason to call 111.
Second, and more urgent: severe, constant stomach pain that spreads to the back, with or without vomiting. This pattern warrants prompt medical attention because GLP-1 medicines carry a known, if uncommon, risk of acute pancreatitis. The MHRA Drug Safety Update from January 2026 specifically flags this for GLP-1 receptor agonists and advises seeking urgent care for this symptom combination.
Third, low blood sugar (hypoglycaemia) if you take insulin or a sulfonylurea alongside Mounjaro: shakiness, sweating, pallor, confusion, or feeling faint. If you treat hypoglycaemia at home, do so, and then contact your prescriber or diabetes team the same day.
Signs of allergic reaction (swelling of the face, lips or throat, difficulty breathing, rapid heartbeat) require an immediate 999 call. These are rare but reported for this medicine class. Some people also notice urinary changes when their symptoms are unsettled, and our page covering Mounjaro and UTI symptoms explains how to tell whether what you are experiencing is related to the medicine or needs separate attention. People who are unsure whether what they're experiencing falls into a concerning category are always better off calling 111 and describing their symptoms than waiting to see if things settle.
Stop the next scheduled dose. That is the first practical step. Mounjaro is a weekly injection, so the excess is already in your system; there is no benefit and some risk in adding more.
Contact your prescriber or pharmacist today if you believe you have taken more than prescribed, even if your symptoms feel manageable. If you are getting treatment through nume, our aftercare team is available seven days a week, see the contact page for how to reach us. You should also let your GP know, because they hold your medical record and may need to adjust any concurrent medicines.
Go to A&E or call 999 immediately if: you cannot stop vomiting; you are showing signs of dehydration (no urination for many hours, dry mouth, dizziness on standing); you have the severe back-radiating abdominal pain described above; you lose consciousness; or you are having an allergic reaction.
Do not try to manage a suspected overdose by simply eating something to counteract the medicine. Tirzepatide's action cannot be reversed at home. There is no antidote. Time and supportive medical care (IV fluids, anti-nausea medication) are the mainstays of treatment in a clinical setting.
For background on who should avoid Mounjaro entirely, or if you want to understand how a tirzepatide overdose is assessed medically, those pages cover the clinical detail in full. If you are considering starting treatment and want to understand what safe, individually reviewed prescribing actually looks like, the free consultation is the right starting point.
Occasionally the concern about taking too much is not accidental at all. Some people using weight-loss medicines experience significant distress around food, eating and body image, and the rigidity of a weekly injection schedule can heighten that distress rather than ease it. If this resonates, please speak to your prescriber honestly. It is a clinical conversation, not a judgement, and it may change the kind of support that's offered alongside treatment.
If you are struggling with thoughts of self-harm, including through misuse of medicines, the Samaritans are available 24 hours a day on 116 123. Your prescriber can also help you access appropriate mental health support through your GP surgery.
On the more routine end, some people worry about overdose because their dose has been increased and they are not sure what to expect. The titration schedule, moving from 2.5 mg upward in steps, is designed specifically to give the body time to adjust. Our Mounjaro treatment page explains the schedule in plain terms, and our clinical team profile on the prescribers page gives a sense of who reviews your treatment at every stage. If you have general questions about how treatment works at nume, the FAQs page covers the most common ones.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.